InterCure reaches NIS 230M war damage settlement with Israel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages
August 24, 2026 7:00 AM EDTÂ Company intends to accelerate the rehabilitation of Canndocs flagship Nir Oz facility, supporting a return to full production and the Companys expansion in the growing German medical cannabis market
NEW YORK and HERZLIYA, Israel, Aug. 24, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (InterCure or the Company), today announced that it has reached a final settlement with the Israeli Tax Authorities and Compensation Fund regarding the Companys claim for indirect damages resulting from the October 7, 2023 attacks and... More
